The European Directorate for the Quality of Medicines & HealthCare (EDQM) of the Council of Europe has launched the 12th Edition of the European Pharmacopoeia.
This edition focuses on the digital era and its role in promoting quality standards for medicines and their ingredients within Europe.
Created by nearly 1,000 experts worldwide, the European Pharmacopoeia is designed to champion scientific excellence, rigorous quality standards and international collaboration.
The platform is newly redesigned and more user-friendly platform, which will enable users to stay connected with a new 365 day license.
Potential users can find the European Pharmacopoeia brochure on the organisation's website, as well as information on how to obtain a license for the document.
To present the full possibilities of the new Ph. Eur. platform, the EDQM has scheduled a free, two-part webinar entitled “Unlocking the potential of the European Pharmacopoeia Online” on 1 July 2025, with an additional session added on 3 July due to high demand. Users who want to know more are strongly encouraged to register.
The European Pharmacopoeia has been contributing to providing access to quality medicines for hundreds of millions of people worldwide for more than 60 years, and the organisation's standards form a legal and scientific basis for the quality control of medicinal products and their ingredients throughout their life cycle.
